Showing 1 posts of 1 posts found.
Facility news from Orient Europharma/NanoCarrier, Catalent and China Biologic, plus new contracts for Emerson Process Management and Biotest Pharma.
Qureight paper argues for fibrosis extent as imaging biomarker in lung disease trials
START and Rome cancer institute partner to expand early-phase trial access in Italy
AbbVie expands Oxford R&D facility with new £120m UK research commitment
MedPharm appoints Jason Mieding as chief operating officer
UKRI backs five hubs developing AI tools for earlier disease detection